Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors

Hak J. Lee, Michael A Liss, Ithaar H. Derweesh

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

Purpose of review: To review current status of partial nephrectomy for treatment of T1b and T2 renal mass, focusing oncological and renal functional outcomes reported in the last 18 months, and to understand the emerging role of minimally invasive surgery (MIS) techniques in nephron-sparing management of T1b/T2 tumors. Recent findings: With recent long-term oncological equivalence to radical nephrectomy and renal functional benefit, partial nephrectomy is becoming an alternate standard to radical nephrectomy in the management of T1b tumors. The role of partial nephrectomy in nonelective treatment of T2 tumors is more controversial; however, recent publication of two large North American series have added to other contemporary work that suggests oncologic equivalence and renal functional benefit compared to radical nephrectomy in select patients. Emerging data demonstrate feasibility of MIS for increasing the proportion of T1b/T2 tumors; however, recent trends analyses demonstrate that the majority of T1b/T2 partial nephrectomy are still carried out by open surgery, and concerns continue about prolonged ischemic times and risk of bleeding in various MIS settings. Summary: Management of T1b and T2 renal masses is transforming with adoption of partial nephrectomy as a safe and feasible surgical option with comparable oncological and improved renal function outcomes compared to radical nephrectomy. MIS techniques play an expanding, though still limited, role, and more robust prospective data is requisite before drawing overarching conclusions.

Original languageEnglish (US)
Pages (from-to)448-452
Number of pages5
JournalCurrent Opinion in Urology
Volume24
Issue number5
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Nephrectomy
Kidney
Minimally Invasive Surgical Procedures
Neoplasms
Bleeding Time
Nephrons
Therapeutics

Keywords

  • cT1b
  • cT2
  • nephron-sparing surgery
  • oncologic outcomes
  • partial nephrectomy
  • renal cell
  • renal function outcomes

ASJC Scopus subject areas

  • Urology

Cite this

Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors. / Lee, Hak J.; Liss, Michael A; Derweesh, Ithaar H.

In: Current Opinion in Urology, Vol. 24, No. 5, 01.01.2014, p. 448-452.

Research output: Contribution to journalReview article

Lee, Hak J. ; Liss, Michael A ; Derweesh, Ithaar H. / Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors. In: Current Opinion in Urology. 2014 ; Vol. 24, No. 5. pp. 448-452.
@article{b3bae06024e447a280c3d5094d4c4af7,
title = "Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors",
abstract = "Purpose of review: To review current status of partial nephrectomy for treatment of T1b and T2 renal mass, focusing oncological and renal functional outcomes reported in the last 18 months, and to understand the emerging role of minimally invasive surgery (MIS) techniques in nephron-sparing management of T1b/T2 tumors. Recent findings: With recent long-term oncological equivalence to radical nephrectomy and renal functional benefit, partial nephrectomy is becoming an alternate standard to radical nephrectomy in the management of T1b tumors. The role of partial nephrectomy in nonelective treatment of T2 tumors is more controversial; however, recent publication of two large North American series have added to other contemporary work that suggests oncologic equivalence and renal functional benefit compared to radical nephrectomy in select patients. Emerging data demonstrate feasibility of MIS for increasing the proportion of T1b/T2 tumors; however, recent trends analyses demonstrate that the majority of T1b/T2 partial nephrectomy are still carried out by open surgery, and concerns continue about prolonged ischemic times and risk of bleeding in various MIS settings. Summary: Management of T1b and T2 renal masses is transforming with adoption of partial nephrectomy as a safe and feasible surgical option with comparable oncological and improved renal function outcomes compared to radical nephrectomy. MIS techniques play an expanding, though still limited, role, and more robust prospective data is requisite before drawing overarching conclusions.",
keywords = "cT1b, cT2, nephron-sparing surgery, oncologic outcomes, partial nephrectomy, renal cell, renal function outcomes",
author = "Lee, {Hak J.} and Liss, {Michael A} and Derweesh, {Ithaar H.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1097/MOU.0000000000000081",
language = "English (US)",
volume = "24",
pages = "448--452",
journal = "Current Opinion in Urology",
issn = "0963-0643",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors

AU - Lee, Hak J.

AU - Liss, Michael A

AU - Derweesh, Ithaar H.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Purpose of review: To review current status of partial nephrectomy for treatment of T1b and T2 renal mass, focusing oncological and renal functional outcomes reported in the last 18 months, and to understand the emerging role of minimally invasive surgery (MIS) techniques in nephron-sparing management of T1b/T2 tumors. Recent findings: With recent long-term oncological equivalence to radical nephrectomy and renal functional benefit, partial nephrectomy is becoming an alternate standard to radical nephrectomy in the management of T1b tumors. The role of partial nephrectomy in nonelective treatment of T2 tumors is more controversial; however, recent publication of two large North American series have added to other contemporary work that suggests oncologic equivalence and renal functional benefit compared to radical nephrectomy in select patients. Emerging data demonstrate feasibility of MIS for increasing the proportion of T1b/T2 tumors; however, recent trends analyses demonstrate that the majority of T1b/T2 partial nephrectomy are still carried out by open surgery, and concerns continue about prolonged ischemic times and risk of bleeding in various MIS settings. Summary: Management of T1b and T2 renal masses is transforming with adoption of partial nephrectomy as a safe and feasible surgical option with comparable oncological and improved renal function outcomes compared to radical nephrectomy. MIS techniques play an expanding, though still limited, role, and more robust prospective data is requisite before drawing overarching conclusions.

AB - Purpose of review: To review current status of partial nephrectomy for treatment of T1b and T2 renal mass, focusing oncological and renal functional outcomes reported in the last 18 months, and to understand the emerging role of minimally invasive surgery (MIS) techniques in nephron-sparing management of T1b/T2 tumors. Recent findings: With recent long-term oncological equivalence to radical nephrectomy and renal functional benefit, partial nephrectomy is becoming an alternate standard to radical nephrectomy in the management of T1b tumors. The role of partial nephrectomy in nonelective treatment of T2 tumors is more controversial; however, recent publication of two large North American series have added to other contemporary work that suggests oncologic equivalence and renal functional benefit compared to radical nephrectomy in select patients. Emerging data demonstrate feasibility of MIS for increasing the proportion of T1b/T2 tumors; however, recent trends analyses demonstrate that the majority of T1b/T2 partial nephrectomy are still carried out by open surgery, and concerns continue about prolonged ischemic times and risk of bleeding in various MIS settings. Summary: Management of T1b and T2 renal masses is transforming with adoption of partial nephrectomy as a safe and feasible surgical option with comparable oncological and improved renal function outcomes compared to radical nephrectomy. MIS techniques play an expanding, though still limited, role, and more robust prospective data is requisite before drawing overarching conclusions.

KW - cT1b

KW - cT2

KW - nephron-sparing surgery

KW - oncologic outcomes

KW - partial nephrectomy

KW - renal cell

KW - renal function outcomes

UR - http://www.scopus.com/inward/record.url?scp=84905364151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905364151&partnerID=8YFLogxK

U2 - 10.1097/MOU.0000000000000081

DO - 10.1097/MOU.0000000000000081

M3 - Review article

C2 - 24921904

AN - SCOPUS:84905364151

VL - 24

SP - 448

EP - 452

JO - Current Opinion in Urology

JF - Current Opinion in Urology

SN - 0963-0643

IS - 5

ER -